PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CXCL16 341 Target Target CCL2 3,560 29 0.03 -0.95 0.09 0.72
CCL3 1,427 Target Target CXCL4/PF4 9 3 0.03 -0.82 0.33 0.72
CCL2 3,560 Target Target CCL21 808 45 0.03 -0.97 0.06 0.73
Endometriosis 16,342 Disease Target Buserelin 1,249 120 0.03 -0.95 0.10 0.70
CCL4 5,638 Target Target CCL8 197 28 0.03 -0.92 0.14 0.71
Epidermal Growth Factor Receptor 24,772 Target Target BRAF 4,766 289 0.03 -0.96 0.06 0.69
Myelodysplastic Syndrome 7,378 Disease Target CD34 24,598 360 0.03 -0.97 0.05 0.69
CCL19 658 Target Target CCL18 256 11 0.03 -0.97 0.04 0.76
CXCL16 341 Target Target CXCL3 145 6 0.03 -0.97 0.04 0.77
Myeloperoxidase 16,181 Target Target Cathepsin G 1,613 138 0.03 -0.95 0.09 0.70
Multidrug Resistance-Associated Protein 2 462 Target Target Multidrug Resistance Protein 1 495 13 0.03 -0.97 0.03 0.77
Abciximab (ReoPro)- FDA 7 Drug Target Eptifibatide 772 2 0.03 -0.84 0.29 0.73
CXCL10/IP-10 114 Target Target CCL3 1,427 11 0.03 -0.95 0.10 0.74
Colon Cancer 30,064 Disease Target CEA 17,022 618 0.03 -0.97 0.04 0.69
CCL19 658 Target Target CXCL16 341 13 0.03 -0.97 0.04 0.76
BMP-4 1,255 Target Target Activin A 2,048 44 0.03 -0.97 0.04 0.75
CCL7 274 Target Target CXCL7 76 4 0.03 -0.97 0.05 0.77
Carcinoma 433,099 Disease Target Ret Proto-Oncogene 1,005 580 0.03 -0.65 0.58 0.63
Osteoarthritis 36,287 Disease Target Collagen 138,882 1,976 0.03 -0.97 0.05 0.65
EPHA2 532 Target Target EPHB3 118 7 0.03 -0.96 0.06 0.76
CXCL3 145 Target Target CCL1 220 5 0.03 -0.97 0.03 0.78
ELC 355 Target Target CCL21 808 15 0.03 -0.97 0.04 0.76
Aurora Kinase A 196 Target Target AURKC 26 2 0.03 -0.96 0.08 0.77
CCL7 274 Target Target Eotaxin 2,457 23 0.03 -0.95 0.08 0.73
CCL19 658 Target Target CCL7 274 12 0.03 -0.97 0.04 0.76
EDF 379 Target Target Activin A 2,048 25 0.03 -0.96 0.07 0.74
Colon Cancer 30,064 Disease Target Cox-2 21,583 724 0.03 -0.97 0.03 0.69
AFP 9,751 Target Target Chorionic Gonadotropin beta 936 86 0.03 -0.95 0.09 0.71
Adenosine A1 Receptor 1,432 Target Target Adenosine Deaminase 6,613 88 0.03 -0.96 0.06 0.72
CCL18 256 Target Target CXCL7 76 4 0.03 -0.97 0.05 0.77
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
Calmodulin 25,240 Target Target CAMK4 43 30 0.03 -0.55 0.70 0.69
CXCL7 76 Target Target CCL2 3,560 15 0.03 -0.89 0.20 0.72
Thromboembolic Disease 3,336 Disease Target Antithrombin 13,773 196 0.03 -0.96 0.06 0.71
CCL7 274 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
Graft Versus Host Disease 15,741 Disease Target CD34 24,598 573 0.03 -0.97 0.04 0.70
Alpha-Amylase 7,171 Target Target AMY1A 13 9 0.03 -0.55 0.69 0.70
Glutaredoxin-1 142 Target Target Glutathione S-Transferase Mu 2 8 1 0.03 -0.93 0.12 0.77
Deep Vein Thrombosis 10,952 Disease Target Antithrombin 13,773 365 0.03 -0.97 0.03 0.72
Epidermal Growth Factor Receptor 24,772 Target Target Epiregulin 291 80 0.03 -0.85 0.27 0.69
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72
CCL18 256 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
CD68 6,424 Target Target CD4 112,219 808 0.03 -0.93 0.13 0.66
CCL7 274 Target Target CCL18 256 8 0.03 -0.97 0.03 0.78
CXCL16 341 Target Target CCL5 2,002 25 0.03 -0.96 0.07 0.74
Endostatin 1,599 Target Target Angiostatin K1-3 17 5 0.03 -0.84 0.29 0.73
CCL4 5,638 Target Target CCL1 220 34 0.03 -0.92 0.15 0.72
CXCL3 145 Target Target CXCL10 2,386 18 0.03 -0.93 0.12 0.73
Aldosterone Receptor 528 Target Target Renin 43,456 147 0.03 -0.85 0.28 0.68
Cancer 1,053,491 Disease Target EGF 27,487 5,238 0.03 -0.90 0.19 0.61